The post Modern Treasury’s Stablecoin PSP: Beam Integration appeared on BitcoinEthereumNews.com. Modern Treasury, a payments software provider that helps companiesThe post Modern Treasury’s Stablecoin PSP: Beam Integration appeared on BitcoinEthereumNews.com. Modern Treasury, a payments software provider that helps companies

Modern Treasury’s Stablecoin PSP: Beam Integration

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Modern Treasury, a payments software provider that helps companies manage their money movements, has launched an integrated payment service provider (PSP) supporting traditional fiat rails and stablecoins. The company announced on Wednesday that it has added stablecoin settlement to its existing ACH transfers, wire payments, and real-time payment network infrastructure. This move enables businesses to unify crypto and fiat payments on a single platform, increasing operational efficiency.

Modern Treasury’s New PSP Launch and Features

In the launch, the infrastructure integrated with BEAM detailed analysis adds stablecoin support to traditional rails like ACH, wire, and RTP. Businesses can now make low-cost cross-border payments in seconds. Technically, the settlement layer synchronizes with blockchain-based ledgers to minimize delays; for example, USDC transfers complete in 1-2 seconds.

Supported Stablecoins and Expansion Plans

At launch, Global Dollar (USDG), Pax Dollar (USDP), and USDC (USDC) are supported; USDT (USDT) will be added soon. These stablecoins are selected from regulated issuers to reduce compliance risk.

  • USDG: Based on Global Dollar Network, institutional focus.
  • USDP: Fully reserved with Paxos backing.
  • USDC: Circle’s high liquidity network.

Beam Acquisition and Technical Integration

Modern Treasury acquired the stablecoin and fiat payment platform BEAM futures trading in October 2025. Beam’s infrastructure adds a privacy-focused settlement layer to the PSP. Post-acquisition, the BEAM token is showing downtrend signals: RSI 19.24 (Oversold), Supertrend bearish, below EMA 20 $0.0932.

Level Price Score Distance Sources
S1 $0.0615 78/100 ⭐ Strong -5.67% Fibo 0.000, Donchian Lower
S2 $0.0266 54/100 Medium -59.20% Fibo 1.272
R1 $0.0658 69/100 ⭐ Strong +0.92% Prev Day Close, MACD Cross
R2 $0.0761 67/100 ⭐ Strong +16.72% ATR Upper, Fibo 0.114

Strategic Partnerships and Compliance Framework

The company partnered with Paxos to integrate regulated stablecoins, joined the Global Dollar Network, and joined Circle’s Alliance Program. This allows stablecoins to be managed within a single compliance framework alongside traditional banking rails; companies no longer need separate vendors. Expert insight: This could shorten KYC/AML processes by 40%.

Growth in the Stablecoin Market and Bank Moves

The stablecoin market grew 50% in 2025, exceeding 300 billion dollars. JPMorgan Chase, Bank of America, Citigroup, and Wells Fargo are discussing a joint stablecoin initiative. Fidelity Investments announced the Fidelity Digital Dollar stablecoin. These developments position Modern Treasury’s PSP strategically for institutional adoption; infrastructure coins like LINK analysis could also benefit indirectly.

Market Analyst: Sarah Chen

Technical analysis and risk management specialist

This analysis is not investment advice. Do your own research.

Source: https://en.coinotag.com/modern-treasurys-stablecoin-psp-beam-integration

Market Opportunity
BEAM Logo
BEAM Price(BEAM)
$0.02332
$0.02332$0.02332
+6.19%
USD
BEAM (BEAM) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09